This study evaluates whether a sedation with inhaled sevoflurane will decrease mortality and
increase time off the ventilator at 28 days in patients with acute respiratory distress
syndrome (ARDS).
Half of the patients will receive inhaled sedation with sevoflurane and the other half will
receive intravenous sedation with propofol.